Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
1. To evaluate the efficacy of Cilostazol and Probucol alone and in combination on
atherosclerosis related biomarker
2. To evaluate the safety of Cilostazol and Probucol alone and in combination on
atherosclerosis related biomarker